HOME >> MEDICINE >> NEWS
UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells

Researchers at UCLA have successfully manipulated nanomaterials to create a new drug-delivery system that promises to solve the challenge of the poor water solubility of todays most promising anticancer drugs and thereby increase their effectiveness.

The poor solubility of anticancer drugs is one of the major problems in cancer therapy because the drugs require the addition of solvents in order to be easily absorbed into cancer cells. Unfortunately, these solvents not only dilute the potency of the drugs but create toxicity as well.

In a paper scheduled to be published in the nanoscience journal Small in June, researchers from UCLAs California NanoSystems Institute and Jonsson Cancer Center report a novel approach using silica-based nanoparticles to deliver the anticancer drug camptothecin and other water-insoluble drugs into human cancer cells.

The study is led by Fuyu Tamanoi, UCLA professor of microbiology, immunology and molecular genetics and director of the Jonsson Cancer Centers Signal Transduction and Therapeutics Program Area, and Jeffrey Zink, UCLA professor of chemistry and biochemistry.

Tamanoi and Zink devised a method for incorporating the representative hydrophobic anticancer drug camptothecin into the pores of fluorescent mesoporous silica nanoparticles and delivering the particles into a variety of human cancer cells to induce cell death. The results suggest that the mesoporous silica nanoparticles might be used as a vehicle to overcome the insolubility problem of many anticancer drugs.

Silica nanomaterials show promise for delivering camptothecin and other water-insoluble drugs, Tamanoi said. We have successfully loaded hydrophobic anticancer drugs into mesoporous nanoparticles and delivered them into human cancer cells to induce cell death.

The beauty of our findings is that these nanoparticles are biocompatible, contain tubular pores and are relatively easy to modify, Zink said. A
'"/>

Contact: Jennifer Marcus
jmarcus@cnsi.ucla.edu
310-267-4839
University of California - Los Angeles
6-Jun-2007


Page: 1 2

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
3. Penn researchers discover novel pathway for increasing good cholesterol
4. Theory of facial aging gets a facelift from UT Southwestern researchers
5. UIC researchers to develop new drugs to fight bioterrorism
6. UQ researchers discover some of the oldest forms of life
7. U of M researchers discover new method to combat HIV
8. U of M researchers assess effectiveness of computerized physician order entry system
9. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
10. Physician-researchers often less successful in obtaining NIH funding
11. Cedars-Sinai researchers present new endocrine findings at 2 international conferences

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2019)... , ... September 21, 2019 , ... ... that he has been certified by the American Academy of Facial Esthetics (AAFE) ... professional medical-grade skin care products. , Dr. Patel has also been certified by ...
(Date:9/18/2019)... YORK (PRWEB) , ... September 18, 2019 , ... DOROT hosts its annual Rosh Hashanah ... from which more than 700 volunteers will be heading out to visit our seniors. , ... , The Upper East Side, at Central Synagogue 123 East 55st Street , ...
(Date:9/17/2019)... , ... September 17, 2019 , ... ... winner Meb Keflezighi and the American Heart Association (AHA)-San Diego Chapter to raise ... Heart and Stroke Walk on Saturday, September 21 in Balboa Park alongside National ...
(Date:9/17/2019)... ... September 17, 2019 , ... Dr. Jacqueline ... laser dentistry . A minimally invasive approach to gum surgery, laser dentistry ... , Laser dentistry is gentle and effective because it simply uses laser light ...
(Date:9/17/2019)... CHICAGO (PRWEB) , ... September 17, 2019 , ... ... cocktail reception fundraiser. Gather for GRIN2B will be held at Found Kitchen ... p.m. , Proceeds will help fund research on GRIN2B-Related Neurodevelopmental Disorder, a rare condition ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... MILWAUKEE (PRWEB) , ... September 13, 2019 , ... The ... voted, based on the available safety and efficacy data, to recommend approval of a ... be Palforzia, but it was previously referred to as AR101. , The FDA would ...
(Date:9/14/2019)... ... September 14, 2019 , ... CME4Life, a leading provider ... announcing its attempt at a world record “Longest Medical Lecture” on November 16, ... while earning 30 CME credits in 30 consecutive hours. ?The conference will take ...
(Date:9/12/2019)... ... September 12, 2019 , ... Stratosphere Networks will ... will take place on Monday, October 7 at Found Kitchen and Social House in ... fund research on GRIN2B-Related Neurodevelopmental Disorder. GRIN2B is a gene on the short arm ...
Breaking Medicine Technology:
Cached News: